机构:[1]Medical College, Yangzhou University, Yangzhou, China[2]The Yangzhou School of Clinical Medicine of Nanjing Medical University, Yangzhou, China[3]Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, China江苏省人民医院[4]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China外科中心胸外科中心四川省肿瘤医院[5]Department of Radiation Oncology, Suzhou Municipal Hospital, Suzhou, China[6]First College of Clinical Medicine, Dalian Medical University, Dalian, China[7]Yangzhou Key Laboratory of Thoracic and Cardiac Surgery, Yangzhou, China[8]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Innovation Institute for Pharmaceutical Basic Research, Innovative Institute of Tumor Immunity and Medicine (ITIM), Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China
This study was supported by the Jiangsu Provincial Health Commission Research Project on Elderly Health (LKZ2022019), Yangzhou
Social Development and Clinical Frontier Technology Project
(YZ2023084), Yangzhou Innovation Capability Building Design Plan
Project (YZ2022168) and Yangzhou Social Development and Clinical
Frontier Technology Project (YZ2021078).
第一作者机构:[1]Medical College, Yangzhou University, Yangzhou, China[3]Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, China[7]Yangzhou Key Laboratory of Thoracic and Cardiac Surgery, Yangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Medical College, Yangzhou University, Yangzhou, China[2]The Yangzhou School of Clinical Medicine of Nanjing Medical University, Yangzhou, China[3]Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, China[7]Yangzhou Key Laboratory of Thoracic and Cardiac Surgery, Yangzhou, China[8]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Innovation Institute for Pharmaceutical Basic Research, Innovative Institute of Tumor Immunity and Medicine (ITIM), Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China[*1]Medical College, Yangzhou University, Yangzhou, China[*2]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Innovation Institute for Pharmaceutical Basic Research, Innovative Institute of Tumor Immunity and Medicine (ITIM), Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei, China[*3]The Yangzhou School of Clinical Medicine of Nanjing Medical University, Yangzhou, China.
推荐引用方式(GB/T 7714):
Wu Jun,Chen Yong,Zou Hui,et al.6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells[J].Cancer Letters.2024,601:217177.doi:10.1016/j.canlet.2024.217177.
APA:
Wu Jun,Chen Yong,Zou Hui,Xu Kaiyue,Hou Jiaqi...&Wang Xiaolin.(2024).6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells.Cancer Letters,601,
MLA:
Wu Jun,et al."6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells".Cancer Letters 601.(2024):217177